GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -33.3% | 48 | -26.2% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | 0.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,000 | +50.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | -75.0% | 65 | -67.8% | 0.00% | -66.7% |
| Q2 2021 | $8,000 | -11.1% | 202 | -15.1% | 0.00% | 0.0% |
| Q1 2021 | $9,000 | -99.5% | 238 | -99.5% | 0.00% | -99.6% |
| Q4 2020 | $1,860,000 | +2.4% | 50,541 | +4.7% | 0.72% | -8.3% |
| Q3 2020 | $1,816,000 | -2.0% | 48,255 | +6.2% | 0.79% | -0.8% |
| Q2 2020 | $1,854,000 | +9.4% | 45,453 | +1.7% | 0.79% | -7.3% |
| Q1 2020 | $1,694,000 | -16.3% | 44,701 | +3.7% | 0.85% | -0.2% |
| Q4 2019 | $2,025,000 | +5.2% | 43,091 | -4.5% | 0.86% | -2.7% |
| Q3 2019 | $1,925,000 | +11.5% | 45,114 | +4.6% | 0.88% | +5.3% |
| Q2 2019 | $1,727,000 | -20.9% | 43,149 | -17.4% | 0.84% | -26.3% |
| Q1 2019 | $2,184,000 | +5.0% | 52,262 | -4.0% | 1.13% | -6.3% |
| Q4 2018 | $2,080,000 | – | 54,449 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |